Lucile Dho, Said Ait Taleb, Lyna Kireche, Pascal Rathelot, Nicolas Primas, Christophe Jean, Patrice Vanelle, Arnaud Venet, Christophe Curti
{"title":"Compounding and Stability Study of Dipyridamole and Clopidogrel Pediatric Oral Suspensions.","authors":"Lucile Dho, Said Ait Taleb, Lyna Kireche, Pascal Rathelot, Nicolas Primas, Christophe Jean, Patrice Vanelle, Arnaud Venet, Christophe Curti","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Dipyridamole and clopidogrel are two antiplatelet agents that can be prescribed off-label in pediatric practice. As commercially available drugs are unavailable, pediatric formulations must be compounded. Both stability-indicating HPLC dosing assays and microbiological methods were validated and described. Stabilities of dipyridamole and clopidogrel in Syrspend® pH4 were studied. The stability study of clopidogrel involved two complementary HPLC methods (RP-HPLC and chiral HPLC). Oral suspension of 10 mg.mL-1 dipyridamole is stable for 3 months at +2/+8°C before opening, 1.5 month at +2/+8°C after opening, and 15 days at 25°C/60% RH. Oral suspension of 5 mg.mL-1 clopidogrel bisulfate is stable only for 1 month at +2/+8°C before or after opening and for 7 days at 25°C/60% RH.</p>","PeriodicalId":14381,"journal":{"name":"International journal of pharmaceutical compounding","volume":"30 2","pages":"184-196"},"PeriodicalIF":0.0000,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of pharmaceutical compounding","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Dipyridamole and clopidogrel are two antiplatelet agents that can be prescribed off-label in pediatric practice. As commercially available drugs are unavailable, pediatric formulations must be compounded. Both stability-indicating HPLC dosing assays and microbiological methods were validated and described. Stabilities of dipyridamole and clopidogrel in Syrspend® pH4 were studied. The stability study of clopidogrel involved two complementary HPLC methods (RP-HPLC and chiral HPLC). Oral suspension of 10 mg.mL-1 dipyridamole is stable for 3 months at +2/+8°C before opening, 1.5 month at +2/+8°C after opening, and 15 days at 25°C/60% RH. Oral suspension of 5 mg.mL-1 clopidogrel bisulfate is stable only for 1 month at +2/+8°C before or after opening and for 7 days at 25°C/60% RH.
期刊介绍：
The International Journal of Pharmaceutical Compounding (IJPC) is a bi-monthly, scientific and professional journal emphasizing quality pharmaceutical compounding. IJPC is the only publication that covers pharmaceutical compounding topics relevant and necessary to empower pharmacists to meet the needs of today"s patients. No other publication features hands-on, how-to compounding techniques or the information that contemporary pharmacists need to provide individualized care.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
